Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; Tonic Study Group. Young CA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):82-90. doi: 10.1080/21678421.2022.2096410. Epub 2022 Sep 6. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36066075
The sex ratio in amyotrophic lateral sclerosis: A population based study.
Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, Turner MR, Ampong MA, Sakel M, Orrell RW, Howard R, Shaw CE, Leigh PN, Al-Chalabi A. Manjaly ZR, et al. Amyotroph Lateral Scler. 2010 Oct;11(5):439-42. doi: 10.3109/17482961003610853. Amyotroph Lateral Scler. 2010. PMID: 20225930 Free PMC article.
Prognostic categories for amyotrophic lateral sclerosis.
Scotton WJ, Scott KM, Moore DH, Almedom L, Wijesekera LC, Janssen A, Nigro C, Sakel M, Leigh PN, Shaw C, Al-Chalabi A. Scotton WJ, et al. Amyotroph Lateral Scler. 2012 Oct;13(6):502-8. doi: 10.3109/17482968.2012.679281. Epub 2012 Jun 7. Amyotroph Lateral Scler. 2012. PMID: 22670880
Management of sialorrhoea in motor neuron disease: a survey of current UK practice.
Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, Donaghy C, Ealing J, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Majeed T, Malaspina A, Morrison K, Orrell RW, Pall H, Pinto A, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. Hobson EV, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):521-7. doi: 10.3109/21678421.2013.790452. Epub 2013 May 7. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23647474
Genetic and epigenetic studies of amyotrophic lateral sclerosis.
Al-Chalabi A, Kwak S, Mehler M, Rouleau G, Siddique T, Strong M, Leigh PN. Al-Chalabi A, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:44-52. doi: 10.3109/21678421.2013.778571. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23678879 Review.
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Cudkowicz ME, van den Berg LH, Shefner JM, Mitsumoto H, Mora JS, Ludolph A, Hardiman O, Bozik ME, Ingersoll EW, Archibald D, Meyers AL, Dong Y, Farwell WR, Kerr DA; EMPOWER investigators. Cudkowicz ME, et al. Lancet Neurol. 2013 Nov;12(11):1059-67. doi: 10.1016/S1474-4422(13)70221-7. Epub 2013 Sep 23. Lancet Neurol. 2013. PMID: 24067398 Clinical Trial.
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
Balendra R, Jones A, Jivraj N, Steen IN, Young CA, Shaw PJ, Turner MR, Leigh PN, Al-Chalabi A; UK-MND LiCALS Study Group, Mito Target ALS Study Group. Balendra R, et al. J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):45-9. doi: 10.1136/jnnp-2013-306865. Epub 2014 Jan 24. J Neurol Neurosurg Psychiatry. 2015. PMID: 24463480 Free article.
Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study.
Martin NH, Landau S, Janssen A, Lyall R, Higginson I, Burman R, McCrone P, Sakel M, Ellis CM, Shaw CE, Al-Chalabi A, Leigh PN, Goldstein LH. Martin NH, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):376-87. doi: 10.3109/21678421.2014.886700. Epub 2014 Mar 6. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24597488
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
Jones AR, Jivraj N, Balendra R, Murphy C, Kelly J, Thornhill M, Young C, Shaw PJ, Leigh PN, Turner MR, Steen IN, McCrone P, Al-Chalabi A. Jones AR, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):285-91. doi: 10.3109/21678421.2013.872149. Epub 2014 Feb 7. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24641613
416 results